✦ LIBER ✦

Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4

✍ Scribed by A. R. N. Zekri; H. A. Haleem; G. E. -D. Esmat; A. A. Bahnassy; H. M. A. El-Din; M. M. Hafez; A. F. Sharaby; H. Sharaf; M. S. E.-D. Zakaria

Book ID: 108885985
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 515 KB
Volume: 14
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2006.00832.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDEN

630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B

✍ A. Mangia; O. Dalgard; N. Minerva; H. Verbaan; G. Scotto; D. Bacca; E. Agostinac 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Association of IFNL4 genotype and ALT de

Association of IFNL4 genotype and ALT decrease is a new tool to predict viral eradication in HCV Sardinian patients with chronic hepatitis C, genotype 4, treated with PEG-IFNα and Ribavirin

✍ Chessa, L.; Genovese, D.; Catone, S.; Figorilli, F.; Onali, S.; Argentini, C.; B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

P732 PREDICTIVE VALUE OF THE INTERFERON-

P732 PREDICTIVE VALUE OF THE INTERFERON-LAMBDA 4 GENE (IFN-L4) FOR DIRECT-/ANTIVIRAL TREATMENT IN HEPATITIS C VIRUS INFECTED PATIENTS WITH GENOTYPES 1, 2, 3, AND 4

✍ Susser, S.; Lange, C.M.; Hamdi, N.; Berg, T.; Perner, D.; Zeuzem, S.; Sarrazin, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Ribavirin pharmacokinetics and interleuk

Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4

✍ Antonio D'Avolio; Alessia Ciancio; Marco Siccardi; Lorena Baietto; Marco Simiele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong

Prediction of nonSVR to therapy with peg

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB